Alnylam Pharmaceuticals, Inc. (ALNY)
USD 241.95
(-7.71%)
USD 241.95
(-7.71%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.34 Billion USD | 83.29% |
| 2022 | 1.27 Billion USD | 89.18% |
| 2021 | 675.69 Million USD | 253.25% |
| 2020 | 191.27 Million USD | -30.73% |
| 2019 | 276.13 Million USD | 820.45% |
| 2018 | 30 Million USD | 0.0% |
| 2017 | 30 Million USD | -80.0% |
| 2016 | 150 Million USD | 0.0% |
| 2015 | - USD | 100.0% |
| 2014 | -31.66 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 2.96 Million USD | -49.94% |
| 2006 | 5.91 Million USD | 7.25% |
| 2005 | 5.51 Million USD | -13.91% |
| 2004 | 6.41 Million USD | 392.77% |
| 2003 | 1.3 Million USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 2.35 Billion USD | 0.67% |
| 2024 Q2 | 2.36 Billion USD | 0.28% |
| 2024 Q3 | 1.25 Billion USD | -56.72% |
| 2023 Q4 | 2.34 Billion USD | 84.85% |
| 2023 FY | 2.34 Billion USD | 83.29% |
| 2023 Q3 | 1.26 Billion USD | -0.37% |
| 2023 Q1 | 1.27 Billion USD | -0.08% |
| 2023 Q2 | 1.27 Billion USD | -0.39% |
| 2022 Q3 | 1.28 Billion USD | 35.02% |
| 2022 Q2 | 949.73 Million USD | -0.46% |
| 2022 Q1 | 954.09 Million USD | 41.2% |
| 2022 FY | 1.27 Billion USD | 89.18% |
| 2022 Q4 | 1.27 Billion USD | -0.31% |
| 2021 Q4 | 675.69 Million USD | -6.13% |
| 2021 FY | 675.69 Million USD | 253.25% |
| 2021 Q3 | 719.82 Million USD | -0.26% |
| 2021 Q1 | 479.6 Million USD | 150.74% |
| 2021 Q2 | 721.71 Million USD | 50.48% |
| 2020 Q1 | 275.78 Million USD | -0.13% |
| 2020 Q2 | 281.61 Million USD | 2.12% |
| 2020 Q3 | 297.26 Million USD | 5.56% |
| 2020 Q4 | 191.27 Million USD | -35.65% |
| 2020 FY | 191.27 Million USD | -30.73% |
| 2019 Q1 | 329.27 Million USD | 997.59% |
| 2019 FY | 276.13 Million USD | 820.45% |
| 2019 Q4 | 276.13 Million USD | -0.12% |
| 2019 Q3 | 276.45 Million USD | 821.52% |
| 2019 Q2 | 30 Million USD | -90.89% |
| 2018 Q1 | 30 Million USD | 0.0% |
| 2018 Q2 | 30 Million USD | 0.0% |
| 2018 FY | 30 Million USD | 0.0% |
| 2018 Q4 | 30 Million USD | 0.0% |
| 2018 Q3 | 30 Million USD | 0.0% |
| 2017 Q3 | 150 Million USD | 0.0% |
| 2017 Q1 | 150 Million USD | 0.0% |
| 2017 FY | 30 Million USD | -80.0% |
| 2017 Q4 | 30 Million USD | -80.0% |
| 2017 Q2 | 150 Million USD | 0.0% |
| 2016 Q4 | 150 Million USD | 0.0% |
| 2016 Q3 | 150 Million USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q2 | 150 Million USD | 0.0% |
| 2016 FY | 150 Million USD | 0.0% |
| 2015 Q2 | -19.65 Million USD | 41.62% |
| 2015 Q1 | -33.66 Million USD | -6.32% |
| 2015 Q3 | -9.4 Million USD | 52.14% |
| 2015 Q4 | - USD | 100.0% |
| 2015 FY | - USD | 100.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | -31.66 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | -31.66 Million USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2008 Q3 | 719 Thousand USD | -23.35% |
| 2008 Q4 | - USD | -100.0% |
| 2008 Q2 | 938 Thousand USD | -52.02% |
| 2008 Q1 | 1.95 Million USD | -34.02% |
| 2008 FY | - USD | -100.0% |
| 2007 FY | 2.96 Million USD | -49.94% |
| 2007 Q3 | 3.94 Million USD | -19.57% |
| 2007 Q2 | 4.9 Million USD | -3.14% |
| 2007 Q1 | 5.06 Million USD | -14.43% |
| 2007 Q4 | 2.96 Million USD | -24.91% |
| 2006 Q2 | 6.33 Million USD | 19.06% |
| 2006 Q3 | 6.43 Million USD | 1.63% |
| 2006 FY | 5.91 Million USD | 7.25% |
| 2006 Q1 | 5.32 Million USD | -3.61% |
| 2006 Q4 | 5.91 Million USD | -8.05% |
| 2005 Q4 | 5.51 Million USD | -4.55% |
| 2005 Q2 | 6.18 Million USD | -4.49% |
| 2005 Q1 | 6.47 Million USD | 1.05% |
| 2005 FY | 5.51 Million USD | -13.91% |
| 2005 Q3 | 5.78 Million USD | -6.55% |
| 2004 Q1 | 1.87 Million USD | 44.43% |
| 2004 FY | 6.41 Million USD | 392.77% |
| 2004 Q4 | 6.41 Million USD | -2.73% |
| 2004 Q3 | 6.59 Million USD | 15.53% |
| 2004 Q2 | 5.7 Million USD | 203.62% |
| 2003 Q4 | 1.3 Million USD | 0.0% |
| 2003 FY | 1.3 Million USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -3189.748% |
| Alkermes plc | 287.73 Million USD | -714.313% |
| Agenus Inc. | 137.32 Million USD | -1606.201% |
| Aptorum Group Limited | 3.05 Million USD | -76506.964% |
| Ardelyx, Inc. | 51.54 Million USD | -4445.413% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -2139.813% |
| Bicycle Therapeutics plc | 40.08 Million USD | -5745.868% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -2229.096% |
| ChromaDex Corporation | 2.57 Million USD | -90891.223% |
| Chimerix, Inc. | 125 Thousand USD | -1874319.2% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -72246.124% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -8943.631% |
| CRISPR Therapeutics AG | 223 Million USD | -950.65% |
| Precision BioSciences, Inc. | 7.72 Million USD | -30238.262% |
| Dyadic International, Inc. | 88.87 Thousand USD | -2636362.248% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -10650009.091% |
| Fortress Biotech, Inc. | 60.85 Million USD | -3750.112% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -3809942.93% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -61542.305% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -2599678.084% |
| Incyte Corporation | 29.16 Million USD | -7934.511% |
| IO Biotech, Inc. | 1.83 Million USD | -127307.504% |
| Jaguar Health, Inc. | 30.99 Million USD | -7459.849% |
| Novavax, Inc. | 168.01 Million USD | -1294.524% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -10076.0% |
| Opthea Limited | 200.53 Million USD | -1068.382% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -40612.841% |
| ContextLogic Inc. | 6 Million USD | -38950.4% |
| MiMedx Group, Inc. | 48.09 Million USD | -4771.253% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -11557.416% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -6118894.019% |
| NextCure, Inc. | 5.94 Million USD | -39285.174% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -1615778.621% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -10496.644% |
| PDS Biotechnology Corporation | 19.5 Million USD | -11911.699% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -1928.944% |
| Pharming Group N.V. | 166.1 Million USD | -1310.568% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -37611.637% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -6890.971% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -194180.597% |
| Acelyrin, Inc. | 1.19 Million USD | -196133.166% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -509253.043% |
| Summit Therapeutics Inc. | 103.29 Million USD | -2168.394% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -62065.667% |
| Senti Biosciences, Inc. | 33.53 Million USD | -6886.177% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -48989.126% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -6680.368% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -3784.259% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -149137.197% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -9123.051% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -2145.609% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -319985.246% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -20836.681% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -1594.112% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -17334.511% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -15520.16% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -1127.151% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -4349.512% |
| Fortress Biotech, Inc. | 60.85 Million USD | -3750.112% |
| Precigen, Inc. | 5.89 Million USD | -39645.954% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -5480.223% |
| AlloVir, Inc. | 16.64 Million USD | -13973.907% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -3463.155% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -2306.557% |
| ImmuCell Corporation | 10.54 Million USD | -22128.783% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -208168.8% |
| Onconetix, Inc. | 118.85 Thousand USD | -1971196.6% |
| PureTech Health plc | 18.25 Million USD | -12738.488% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -2366590.909% |
| Elevation Oncology, Inc. | 30.13 Million USD | -7674.576% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -8924.126% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -5364.906% |
| Innoviva, Inc. | 446.23 Million USD | -425.066% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -281175.39% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -3505112.136% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -1032.071% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -3190.949% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -73395.107% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -225624.855% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -10394.598% |
| Aptose Biosciences Inc. | 621 Thousand USD | -377198.551% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -231668.246% |
| Century Therapeutics, Inc. | 46.65 Million USD | -4921.698% |
| Kura Oncology, Inc. | 9.33 Million USD | -25007.415% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -8675.371% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -1697743.478% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -24865.626% |
| Autolus Therapeutics plc | 47.91 Million USD | -4790.061% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -47658.337% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -34493.592% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -1693.222% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -28808.378% |
| IGM Biosciences, Inc. | 34.67 Million USD | -6657.683% |
| INmune Bio, Inc. | 397 Thousand USD | -590082.368% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -1248.48% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -57691.656% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -1594347.053% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -4607.514% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -4193.612% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -5027.753% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -394.968% |
| Verastem, Inc. | 40.08 Million USD | -5744.993% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -53126.352% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -23204.396% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -35611.385% |
| Histogen Inc. | 4.38 Million USD | -53344.891% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -265548.98% |
| Organovo Holdings, Inc. | 888 Thousand USD | -263754.054% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -7710.08% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -55766.094% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -12300.233% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -2995.144% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -2516466.42% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -8943.98% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -877437.079% |
| Amarin Corporation plc | 8.73 Million USD | -26717.26% |
| Mesoblast Limited | 100.48 Million USD | -2231.762% |
| Turnstone Biologics Corp. | 1.18 Million USD | -196958.368% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -2891.26% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -2149463.303% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -2757.033% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -1133.534% |
| Better Therapeutics, Inc. | 10.34 Million USD | -22542.288% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -10031.996% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -2418.487% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -181248.607% |
| Gritstone bio, Inc. | 40.14 Million USD | -5736.548% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -129063.396% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -1425.476% |
| Insmed Incorporated | 1.19 Billion USD | -96.34% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -36798.016% |
| OmniAb, Inc. | 22.07 Million USD | -10513.925% |
| Alector, Inc. | 30.45 Million USD | -7593.144% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -2207.398% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -29016.739% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -449.239% |
| Aura Biosciences, Inc. | 16.87 Million USD | -13788.702% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -4018.227% |
| Immunic, Inc. | 639 Thousand USD | -366570.423% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -7757.487% |
| Veracyte, Inc. | 7.52 Million USD | -31036.532% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -263.336% |
| FibroGen, Inc. | 89.69 Million USD | -2512.154% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -53924.072% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -1790340.384% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 54.13% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -6332397.297% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -118234.545% |
| TG Therapeutics, Inc. | 100.11 Million USD | -2240.262% |
| Galecto, Inc. | 66 Thousand USD | -3549936.364% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -1722711.765% |
| Fortrea Holdings Inc. | 1.63 Billion USD | -43.532% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -38853.017% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -43313.452% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -129063.396% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -10824.717% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -6309.586% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -453096.132% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -5079.556% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -7563.453% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -5129.731% |
| Vaxxinity, Inc. | 13.26 Million USD | -17567.2% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | -188.811% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -521670.036% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -26558.596% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 13.314% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -741363.291% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -52457.739% |
| Ainos, Inc. | 5.92 Million USD | -39467.708% |
| Pluri Inc. | 29.05 Million USD | -7964.654% |
| Prothena Corporation plc | 10.72 Million USD | -21754.528% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -11703.053% |
| Celularity Inc. | 26.17 Million USD | -8850.697% |
| Rallybio Corporation | 173 Thousand USD | -1354249.133% |
| Cue Biopharma, Inc. | 4.2 Million USD | -55659.733% |
| MeiraGTx Holdings plc | 72.11 Million USD | -3148.83% |
| Omeros Corporation | 329.7 Million USD | -610.643% |
| Humacyte, Inc. | 38.6 Million USD | -5970.01% |
| Immunocore Holdings plc | 82.64 Million USD | -2735.081% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -145158.772% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -65402.488% |
| Blueprint Medicines Corporation | 610.96 Million USD | -283.498% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -160601.235% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -2361.444% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -4712.719% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -2477.556% |
| Pulmatrix, Inc. | 8.32 Million USD | -28037.673% |
| Elicio Therapeutics, Inc. | 6 Million USD | -38904.894% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -17999.838% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -2321.805% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -499478.678% |
| Cytokinetics, Incorporated | 607.37 Million USD | -285.764% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -26856.098% |
| Nutriband Inc. | 79.82 Thousand USD | -2935063.982% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -52152.988% |
| Vor Biopharma Inc. | 31.83 Million USD | -7261.056% |
| Roivant Sciences Ltd. | 477.85 Million USD | -390.32% |
| Evogene Ltd. | 10.65 Million USD | -21894.03% |
| ProKidney Corp. | 3.61 Million USD | -64803.712% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -308598.814% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -8899937.985% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | -34.989% |
| CorMedix Inc. | 517.01 Thousand USD | -453084.736% |
| BioLineRx Ltd. | 6.62 Million USD | -35250.392% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -6260.345% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -3165.948% |
| Atai Life Sciences N.V. | 15.21 Million USD | -15303.484% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -278040.384% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -918732.941% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -5329.951% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -570450.821% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -171048.576% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -353244.523% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -1215.788% |
| Biomea Fusion, Inc. | 7.83 Million USD | -29823.678% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -724.39% |
| Mereo BioPharma Group plc | 5.3 Million USD | -44108.0% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -108877.86% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -398373.469% |
| Absci Corporation | 4.66 Million USD | -50179.485% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -20235.22% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -10223.966% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -23318.531% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -20265.267% |
| Allakos Inc. | 38.21 Million USD | -6031.163% |
| Imunon, Inc. | 1.13 Million USD | -205555.964% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -27052.903% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -280166.029% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -23430140.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -2552.1% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -49656.296% |
| XOMA Corporation | 118.51 Million USD | -1876.935% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -23169.679% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -6219.005% |
| aTyr Pharma, Inc. | 13.76 Million USD | -16919.133% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -29562.286% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -9285.611% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -11496.258% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -15620060.0% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -842138.758% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -16109.25% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | -56.28% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -1720523.031% |
| UroGen Pharma Ltd. | 98.55 Million USD | -2277.474% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -1471.297% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -12188.373% |
| Entera Bio Ltd. | 256 Thousand USD | -915143.75% |
| GH Research PLC | 631 Thousand USD | -371219.176% |
| Lisata Therapeutics, Inc. | 137.00 USD | -1710236396.35% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -364857.009% |
| Xencor, Inc. | 14.64 Million USD | -15902.076% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -1559306.593% |
| Replimune Group, Inc. | 71.99 Million USD | -3154.652% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -1561916.0% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -33343.106% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -1720523.031% |
| Portage Biotech Inc. | 7000.00 USD | -33471671.429% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -353244.523% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -163862.491% |
| OncoCyte Corporation | 2.2 Million USD | -106207.804% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -3501916.292% |
| Purple Biotech Ltd. | 163 Thousand USD | -1437338.037% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -92326.982% |
| scPharmaceuticals Inc. | 38.81 Million USD | -5937.01% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -9181.508% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -3209521.918% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -126344.9% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -8792.607% |
| Curis, Inc. | 1.48 Million USD | -157255.541% |
| Daré Bioscience, Inc. | 3.91 Million USD | -59767.603% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -335713.907% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -39050300.0% |
| BeiGene, Ltd. | 197.61 Million USD | -1085.633% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -256951.454% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -2807.88% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -4415.454% |
| bluebird bio, Inc. | 224.41 Million USD | -944.04% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -295.05% |
| DBV Technologies S.A. | 4.52 Million USD | -51668.095% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -174752.537% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -23950.749% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -62098.673% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -521.059% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -5364.524% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -136360.338% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -252381.034% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -13314.004% |
| MacroGenics, Inc. | 30.19 Million USD | -7659.385% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -13135.18% |
| Prime Medicine, Inc. | 4.35 Million USD | -53676.084% |
| Aditxt, Inc. | 1.04 Million USD | -224813.606% |
| Adagene Inc. | 13.54 Million USD | -17204.417% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -16956.301% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -351.705% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -13607.506% |
| SciSparc Ltd. | 24 Thousand USD | -9762500.0% |
| Vericel Corporation | 81.85 Million USD | -2762.373% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -2756.76% |
| Generation Bio Co. | 89.77 Million USD | -2509.914% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -10461.298% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -1061.068% |
| Invivyd, Inc. | 722 Thousand USD | -324418.56% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -4730.778% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -80138079.654% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -61155.529% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -10186960.87% |
| 2seventy bio, Inc. | 244.01 Million USD | -860.205% |
| ADMA Biologics, Inc. | 130.59 Million USD | -1694.128% |
| Clene Inc. | 7.15 Million USD | -32660.403% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -69297.046% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -846.229% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -212708.719% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -891241.183% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -1116.397% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -8149.213% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -24207.75% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -1998.111% |
| Evaxion Biotech A/S | 8.48 Million USD | -27501.523% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -3027.159% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -3520.527% |
| Trevena, Inc. | 35.23 Million USD | -6550.084% |
| Surrozen, Inc. | 882 Thousand USD | -265548.98% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -37593.436% |
| Cingulate Inc. | 135.09 Thousand USD | -1734201.512% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -9853.796% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -4801.724% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -1301580.0% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -9132.137% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -13337.082% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -250223.077% |
| Statera Biopharma, Inc. | 11.43 Million USD | -20396.853% |
| ImmunityBio, Inc. | 836.95 Million USD | -179.947% |
| Korro Bio, Inc. | 31.21 Million USD | -7405.843% |
| Kineta, Inc. | 150 Thousand USD | -1561916.0% |
| BioVie Inc. | 349.89 Thousand USD | -669538.233% |
| Codexis, Inc. | 12.24 Million USD | -19037.662% |
| Celularity Inc. | 26.17 Million USD | -8850.697% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -4826.977% |
| Celcuity Inc. | 37.03 Million USD | -6226.443% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -1328559.162% |
| Cibus, Inc. | 17.67 Million USD | -13156.897% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -69240.752% |
| Kodiak Sciences Inc. | 100 Million USD | -2243.024% |
| Annexon, Inc. | 29.19 Million USD | -7926.804% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -3525.457% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -208725.668% |
| Avalo Therapeutics, Inc. | 2 Million USD | -117051.2% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | -67.314% |
| Eyenovia, Inc. | 8.95 Million USD | -26057.905% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -3468.473% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -28677.008% |
| Arcellx, Inc. | 50.84 Million USD | -4508.532% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -160601.235% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -10932.225% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -221987.583% |
| Moolec Science SA | 99.04 Thousand USD | -2365491.745% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -8382.763% |
| Geron Corporation | 35.05 Million USD | -6584.614% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -396350.761% |
| Royalty Pharma plc | 6.13 Billion USD | 61.811% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -142593.301% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -7381363.046% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -10021.928% |
| Humacyte, Inc. | 38.6 Million USD | -5970.01% |
| Structure Therapeutics Inc. | 4.01 Million USD | -58285.846% |
| 89bio, Inc. | 24.79 Million USD | -9349.583% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -18743.687% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -125463.987% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -226937.209% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -2254.609% |
| Notable Labs, Ltd. | 1.52 Million USD | -153440.236% |
| Liquidia Corporation | 2.36 Million USD | -99012.69% |
| Mustang Bio, Inc. | 1.97 Million USD | -118354.196% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -16956.301% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -33598.03% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -739024.29% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -4597.604% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -24296.335% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -3577636.719% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -1722711.765% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -37304.598% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -1802226.154% |
| PepGen Inc. | 17.1 Million USD | -13601.895% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -494208.861% |
| United Therapeutics Corporation | 300 Million USD | -681.008% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -9686.659% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -56184.105% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -405267.474% |
| XOMA Corporation | 118.51 Million USD | -1876.935% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -6332397.297% |
| Bionomics Limited | 117.62 Million USD | -1891.893% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -251027.974% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -41665.134% |
| uniQure N.V. | 130.06 Million USD | -1701.425% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -3899.017% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -341448.688% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -53924.072% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -169071.408% |
| Altimmune, Inc. | 175 Thousand USD | -1338770.857% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -504.093% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -41665.134% |
| Compugen Ltd. | 719 Thousand USD | -325772.601% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -46149.98% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -2671.006% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -23495.408% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -36630.271% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -2463.203% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -23495.408% |
| Instil Bio, Inc. | 81.42 Million USD | -2777.453% |
| argenx SE | 15.35 Million USD | -15160.023% |
| Immunome, Inc. | 1.34 Million USD | -174752.537% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -437031.343% |
| Verona Pharma plc | 48.37 Million USD | -4743.561% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -25323.438% |
| Shattuck Labs, Inc. | 3.4 Million USD | -68691.075% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -2756398.824% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -1394557.143% |
| Moolec Science SA | 99.04 Thousand USD | -2365491.745% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -21138.307% |
| AnaptysBio, Inc. | 16.03 Million USD | -14510.114% |
| Design Therapeutics, Inc. | 2.33 Million USD | -100286.632% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -8655006.941% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -38950.4% |
| Achilles Therapeutics plc | 1.07 Million USD | -217653.16% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -25323.438% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -11752628.732% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -13894.526% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -2935063.982% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -31403518.818% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -18023161.538% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -584.131% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -9469.613% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -93621.335% |
| Palisade Bio, Inc. | 90 Thousand USD | -2603260.0% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -1207644.33% |
| Beam Therapeutics Inc. | 159.91 Million USD | -1365.205% |
| Neurogene Inc. | 13.37 Million USD | -17420.556% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -664.642% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -8821.388% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -3916559.423% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -234202.4% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -5684.102% |
| Athira Pharma, Inc. | 1.21 Million USD | -192424.569% |
| Vaccinex, Inc. | 26 Thousand USD | -9011530.769% |
| HCW Biologics Inc. | 6.3 Million USD | -37065.384% |
| XOMA Corporation | 118.51 Million USD | -1876.935% |
| Nektar Therapeutics | 112.62 Million USD | -1980.376% |
| Arvinas, Inc. | 800 Thousand USD | -292778.0% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -16109.25% |
| Merus N.V. | 10.48 Million USD | -22240.046% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -15640.84% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -17347.494% |
| Rezolute, Inc. | 1.66 Million USD | -141046.024% |
| Clene Inc. | 7.15 Million USD | -32660.403% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -3194293.849% |
| BeyondSpring Inc. | 3.36 Million USD | -69549.941% |
| Synlogic, Inc. | 12.49 Million USD | -18657.698% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -7074.865% |
| Krystal Biotech, Inc. | 6.62 Million USD | -35293.112% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -1270.839% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -38976.451% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -4946014.712% |
| MannKind Corporation | 252.15 Million USD | -829.215% |
| Ikena Oncology, Inc. | 7.18 Million USD | -32532.646% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -1177298.995% |
| Gossamer Bio, Inc. | 197.4 Million USD | -1086.912% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -450481.538% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -732.844% |
| Mural Oncology plc | 8.91 Million USD | -26193.615% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -5257.198% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -163063.231% |
| Champions Oncology, Inc. | 6.09 Million USD | -38354.357% |
| REGENXBIO Inc. | 82.22 Million USD | -2749.631% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -474193.476% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -52742.219% |
| Vaxart, Inc. | 2.62 Million USD | -89226.115% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -862476.068% |
| Cellectis S.A. | 36.24 Million USD | -6365.12% |
| Longeveron Inc. | 1.44 Million USD | -161711.05% |
| Repare Therapeutics Inc. | 1.01 Million USD | -231882.574% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | -106.887% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -5133.586% |
| Revolution Medicines, Inc. | 80.57 Million USD | -2807.88% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -72936.908% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -1323642.373% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -1904797.561% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | -223.31% |
| Denali Therapeutics Inc. | 44.98 Million USD | -5108.919% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -18637.821% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -1734201.512% |
| Passage Bio, Inc. | 22.92 Million USD | -10122.172% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -38698.212% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -362036.631% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -11519.261% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -478068.163% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -574935.893% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -197124.242% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -502694.85% |
| OmniAb, Inc. | 22.07 Million USD | -10513.925% |
| Anew Medical, Inc. | 1.54 Million USD | -152044.416% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -7826.337% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -25838.492% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -7436.262% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -57691.656% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -4444.531% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -36699.497% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -16483.084% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -348564.286% |
| Alumis Inc. Common Stock | 30.86 Million USD | -7492.43% |
| Equillium, Inc. | 384 Thousand USD | -610062.5% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -37942.28% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -1451.168% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -4693.519% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -1947518.493% |
| Dominari Holdings Inc. | 3.02 Million USD | -77278.6% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -11849513.109% |
| vTv Therapeutics Inc. | 169 Thousand USD | -1386304.734% |
| Bio-Techne Corporation | 319 Million USD | -634.49% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -4011.434% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -1212.133% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -15107.529% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -18821.295% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -48641.918% |
| Nkarta, Inc. | 82.27 Million USD | -2747.969% |
| BioCardia, Inc. | 982 Thousand USD | -238497.149% |
| Iterum Therapeutics plc | 18.95 Million USD | -12260.329% |